A new survey from the healthcare policy think tank KFF reveals that nearly 1 in 8 adults in the United States has turned to GLP-1 drugs such as Ozempic or …
Search results for
"GLP-1"
-
-
More U.S. adults are being diagnosed with attention-deficit/hyperactivity disorder (ADHD). A recent Centers for Disease Control and Prevention (CDC) report indicates that approximately 15.5 million American adults have ADHD. This …
-
A recent report from the FDA’s Adverse Event Reporting System (FAERS) has linked weight loss drugs like Ozempic and Wegovy to 162 deaths in the U.S. over the past six …
-
Recent research has shown that Wegovy and Ozempic, two popular weight-loss drugs, may reduce the risk of several obesity-related cancers. The findings, published in the July 5 issue of JAMA …
-
The House Ways and Means Committee advanced four bills on Thursday, aiming to allow Medicare to cover weight-loss drugs for certain beneficiaries. The vote, which passed 36-4, is a crucial …